Jian Huang Selected Research

ErbB Receptors (EGF Receptor)

1/2022	The efficacy of adding hyperthermia to the treatment of advanced NSCLC patients based on the states of EGFR.
1/2022	Validation of the Prognostic Stage from the American Joint Committee on Cancer 8th Staging Manual in Luminal B-Like Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
1/2021	Identification of lncRNA-miRNA-mRNA Networks Linked to Non-small Lung Cancer Resistance to Inhibitors of Epidermal Growth Factor Receptor.
8/2020	Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma.
5/2020	Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.
1/2020	Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.
1/2015	The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.
1/2011	Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers.
5/2008	Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
6/2007	Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian Huang Research Topics

Disease

366	Neoplasms (Cancer) 04/2024 - 07/2002
101	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2008
73	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 01/2005
70	Neoplasm Metastasis (Metastasis) 12/2023 - 11/2003
62	Inflammation (Inflammations) 05/2024 - 02/2004
62	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 06/2002
37	Carcinogenesis 09/2023 - 11/2003
34	Infections 04/2024 - 12/2003
33	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 07/2003
29	Carcinoma (Carcinomatosis) 01/2024 - 03/2003
28	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 10/2005
21	Lymphatic Metastasis 01/2024 - 11/2003
20	Hypoxia (Hypoxemia) 05/2024 - 08/2005
20	Lung Neoplasms (Lung Cancer) 02/2024 - 02/2003
20	Pain (Aches) 01/2024 - 05/2002
19	Fibrosis (Cirrhosis) 07/2023 - 04/2003
19	Body Weight (Weight, Body) 01/2023 - 01/2007
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 09/2006
17	COVID-19 09/2023 - 01/2020
16	Stomach Neoplasms (Stomach Cancer) 09/2023 - 02/2006
16	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 02/2007
16	Liver Neoplasms (Liver Cancer) 02/2022 - 03/2008
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2008
15	Necrosis 01/2023 - 12/2005
14	Leukemia 11/2023 - 08/2004
14	Osteoporosis 11/2023 - 02/2011
14	Anemia 06/2023 - 01/2007
13	Wounds and Injuries (Trauma) 02/2024 - 11/2003
13	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 07/2003
12	Sepsis (Septicemia) 09/2023 - 05/2008
12	Liver Cirrhosis (Hepatic Cirrhosis) 03/2023 - 08/2003
11	Aortic Valve Stenosis (Aortic Stenosis) 04/2024 - 09/2015
11	Heart Failure 01/2024 - 09/2011
11	Osteoarthritis 12/2023 - 04/2007
10	Triple Negative Breast Neoplasms 01/2024 - 03/2011
10	Disease Progression 05/2023 - 01/2006
10	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 06/2012
10	Chronic Hepatitis B 03/2022 - 08/2003
9	Hypertension (High Blood Pressure) 01/2024 - 10/2008
9	Glioma (Gliomas) 02/2021 - 02/2009
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 01/2006
8	Cardiac Arrhythmias (Arrythmia) 03/2024 - 02/2004
8	Stroke (Strokes) 02/2024 - 11/2015
8	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 02/2012
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 03/2012
8	Insulin Resistance 01/2024 - 10/2014

Drug/Important Bio-Agent (IBA)

115	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2002
79	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2003
47	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2009
43	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 04/2003
41	Messenger RNA (mRNA)IBA 05/2024 - 03/2005
36	CytokinesIBA 03/2024 - 07/2002
34	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2004
32	Long Noncoding RNAIBA 01/2024 - 10/2013
30	AntigensIBA 08/2023 - 09/2005
22	Hormones (Hormone)IBA 01/2024 - 03/2005
21	IronIBA 03/2024 - 01/2007
21	Peptides (Polypeptides)IBA 01/2024 - 06/2002
20	EnzymesIBA 03/2024 - 06/2004
19	Circular RNAIBA 08/2023 - 10/2018
19	Estrogen ReceptorsIBA 05/2023 - 03/2005
17	LigandsIBA 01/2023 - 08/2004
15	Interleukin-6 (Interleukin 6)IBA 04/2024 - 05/2008
14	LipidsIBA 05/2024 - 04/2011
14	Hemoglobins (Hemoglobin)IBA 05/2024 - 01/2011
13	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2014
13	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 08/2008
13	CateninsIBA 08/2023 - 01/2013
13	Phosphotransferases (Kinase)IBA 01/2023 - 01/2011
13	Estrogens (Estrogen)FDA Link 01/2023 - 03/2005
13	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2007
12	Therapeutic UsesIBA 02/2024 - 01/2006
12	LipopolysaccharidesIBA 11/2023 - 06/2008
12	AutoantibodiesIBA 09/2023 - 03/2008
12	Cisplatin (Platino)FDA LinkGeneric 07/2023 - 08/2011
11	InterferonsIBA 04/2024 - 09/2017
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2023 - 03/2003
11	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2006
10	AntibodiesIBA 03/2024 - 01/2005
10	Transcription Factors (Transcription Factor)IBA 01/2024 - 10/2005
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2005
9	Monoclonal AntibodiesIBA 04/2024 - 11/2006
9	Antiviral Agents (Antivirals)IBA 11/2023 - 10/2013
9	AndrogensIBA 11/2023 - 06/2006
9	Indicators and Reagents (Reagents)IBA 01/2023 - 11/2003
9	AntioxidantsIBA 01/2022 - 01/2011
9	AcidsIBA 01/2022 - 10/2003
8	ChemokinesIBA 04/2024 - 01/2012
8	VaccinesIBA 02/2024 - 06/2002
8	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2011

Therapy/Procedure

168	Therapeutics 04/2024 - 10/2004
45	Drug Therapy (Chemotherapy) 01/2024 - 05/2006
36	Immunotherapy 04/2024 - 11/2005
18	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 07/2003
16	Transcatheter Aortic Valve Replacement 04/2024 - 09/2015
16	Cystectomy 09/2023 - 12/2003
13	Castration 11/2023 - 08/2014
11	Length of Stay 06/2024 - 10/2012
9	Aftercare (After-Treatment) 03/2024 - 03/2005
9	Extracorporeal Membrane Oxygenation 07/2023 - 04/2021